Year: 2011
Type: article
Abstract: A wide variety of imaging approaches have been developed in the past few decades for monitoring tumor oxygenation and hypoxia in vivo. In particular, nuclear medicine has seen the development of several radiolabeled hypoxia markers and is the preferred method for imaging of tumor hypoxia. Hypoxia imaging is increasingly being used in the clinical setting and is progressing from a mere detection method to application in individualization of chemoradiotherapy.
Source: Journal of Nuclear Medicine
Institutions: Duke Medical Center, Duke University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: bronze
Awards: G118854508, Astatine and Iodine Radiolabeled Monoclonal Antibodies, G225025246, G2384775063, G3199277650, G4119534169, Integrated Center for InVivo Microscopy, G4723046995, G51465020, SRC on Primary Tumors of the CNS, G5850682332, Hyperthermia and Perfusion Effects in Cancer Therapy, G9000004099, G9000022339, G929433907
OpenAlex ID: W2035257306